GenoMEL logo
 
 
  GenoMEL is an international research consortium coordinated by the University of Leeds.
  University of Leeds
  Home
  News
  Programme
  Membership
  Participants
  Physician Information
  Patient Information
  Papers
  Exchange Programme
  data sharing
  Knowledge Transfer
  Members Section
  Stage III Melanoma Research Group
  PharmacoGenoMEL
  Contact Us
  Site Map
  Media
  Search Site
  useful links
  View this site in other languages
  Accessibility
  Bestimmungen
Datenschutzbestim-
mungen
Participants
Maryland, USA
 
Group Details Group Members Group Publications
 
Group Details
   

Title and address of our institution

National Cancer Institute
NIH/DHHS
Executive Plaza South
6120 Executive Blvd.
Bethesda, MD 20892-7236
USA

 
 

Title and address of our group

American Melanoma Families Group
Genetic Epidemiology Branch
Division of Cancer Epidemiology and Genetics
National Cancer Institute
NIH/DHHS
Executive Plaza South
6120 Executive Blvd.
Bethesda, MD 20892-7236
USA

 
 

The name, address and contact e-mail, tel of the group leader

Alisa M. Goldstein, Ph.D.
Genetic Epidemiology Branch
Division of Cancer Epidemiology and Genetics
National Cancer Institute
NIH/DHHS
Executive Plaza South
6120 Executive Blvd.
Bethesda, MD 20892-7236
USA

Tele: 01-301-496-4375
Fax: 01-301-402-4489
Email: goldstea@mail.nih.gov

 
 

A paragraph describing the group

Our studies of familial melanoma began in the mid 1970’s as a clinical and epidemiologic evaluation of American families with two or more living members with melanoma. The study has evolved over the years to a more formal genetic epidemiologic investigation of families with three or more living members with melanoma. We have examined and followed over 2000 family members, some for over 25 years. We are actively accruing additional families in the U.S. and can be contacted at the above address.

Participants are evaluated either at the NIH Clinical Center or locally by the study team. The research team currently includes genetic epidemiologists, clinicians (physicians and nurses), and laboratory investigators. The major goals of the study are to investigate the genetic and environmental determinants of melanoma in families without known germline mutations; for families with CDKN2A mutations, to study the contribution of other genetic and environmental factors in the expression of disease, to estimate penetrance, and to examine gene-gene and gene-environment interactions.

 
 

Related Links

 

 
 
 
   
 
   
website design: NKD | email: info@NKD.org.uk | site: www.NKD.org.uk